Affle Agrees to Buy Israeli Ad-Tech Firm Perion for $420 Million
Shareholders will receive $11.70 per share, a 34.5% premium to the recent close.
Already have an account? Sign in.
Shareholders will receive $11.70 per share, a 34.5% premium to the recent close.
Be the first to know when deals break, stocks move, or biotech headlines hit.